MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 106.60 billion. The enterprise value is 53.06 billion.
Market Cap | 106.60B |
Enterprise Value | 53.06B |
Important Dates
The last earnings date was Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 34.28 million shares outstanding. The number of shares has increased by 58.75% in one year.
Current Share Class | n/a |
Shares Outstanding | 34.28M |
Shares Change (YoY) | +58.75% |
Shares Change (QoQ) | +1.18% |
Owned by Insiders (%) | 13.36% |
Owned by Institutions (%) | 5.30% |
Float | 24.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.85 |
P/TBV Ratio | 1.85 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.63 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.14 |
Financial Position
The company has a current ratio of 41.29, with a Debt / Equity ratio of 0.03.
Current Ratio | 41.29 |
Quick Ratio | 40.62 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | -0.12 |
Interest Coverage | -237.19 |
Financial Efficiency
Return on equity (ROE) is -29.88% and return on invested capital (ROIC) is -19.58%.
Return on Equity (ROE) | -29.88% |
Return on Assets (ROA) | -19.30% |
Return on Invested Capital (ROIC) | -19.58% |
Return on Capital Employed (ROCE) | -36.71% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.26% in the last 52 weeks. The beta is 0.87, so MedPacto's price volatility has been lower than the market average.
Beta (5Y) | 0.87 |
52-Week Price Change | -76.26% |
50-Day Moving Average | 3,518.70 |
200-Day Moving Average | 5,635.65 |
Relative Strength Index (RSI) | 35.50 |
Average Volume (20 Days) | 189,005 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -21.81B |
Pretax Income | -20.14B |
Net Income | -20.14B |
EBITDA | -20.27B |
EBIT | -21.81B |
Earnings Per Share (EPS) | -598.00 |
Balance Sheet
The company has 55.48 billion in cash and 1.94 billion in debt, giving a net cash position of 53.54 billion or 1,562.00 per share.
Cash & Cash Equivalents | 55.48B |
Total Debt | 1.94B |
Net Cash | 53.54B |
Net Cash Per Share | 1,562.00 |
Equity (Book Value) | 57.74B |
Book Value Per Share | 1,684.70 |
Working Capital | 55.41B |
Cash Flow
In the last 12 months, operating cash flow was -16.56 billion and capital expenditures -313.89 million, giving a free cash flow of -16.87 billion.
Operating Cash Flow | -16.56B |
Capital Expenditures | -313.89M |
Free Cash Flow | -16.87B |
FCF Per Share | -492.28 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.75% |
Shareholder Yield | -58.75% |
Earnings Yield | -18.89% |
FCF Yield | -15.83% |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
Last Split Date | May 13, 2020 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |